SC 13D Filing

Company

Ocean Biomedical, Inc.

Filed

February 24, 2023

Accession Number

0001493152-23-006020

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →